Trial intelligence / Profile preview

SPSIP Block With Different Volumes of Bupivacaine for Postoperative Analgesia in Breast Surgery

NCT07783386Recruiting

Sponsor
Bursa City Hospital
Start
Mar 2026
Primary completion
Feb 2027
Countries
1
01

Overview

Randomised, double-blind trial of bupivacaine in postoperative pain (3 arms), sponsored by Bursa City Hospital. Primary endpoint: Total Postoperative Tramadol Consumption at 24 hours. Started Mar 2026; status: recruiting.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT07783386.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07783386.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call